Conditions: Borderline Resectable Pancreatic Ductal Adenocarcinoma; Locally Advanced Cholangiocarcinoma; Locally Advanced Pancreatic Adenocarcinoma; Metastatic Cholangiocarcinoma; Metastatic Pancreatic Adenocarcinoma; Stage II Pancreatic Cancer AJCC v8; Stage III Pancreatic Cancer AJCC v8; Stage IV Pancreatic Cancer AJCC v8
Interventions: Procedure: Biopsy Procedure; Drug: Cisplatin; Procedure: Computed Tomography; Biological: Durvalumab; Drug: Fluorouracil; Drug: Gemcitabine; Drug: Irinotecan; Drug: Leucovorin; Drug: Ligritinib; Procedure: Magnetic Resonance Imaging; Drug: Oxaliplatin; Drug: Zimberelimab
Sponsors: Jonsson Comprehensive Cancer Center
Not yet **RECRUITING NOW**
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
